Skip to main content
Premium Trial:

Request an Annual Quote

DeCode Extends Deal with Affymetrix to Use GeneChip

Premium

REYKJAVIK, Iceland--DeCode Genetics has extended its contract with Affymetrix to gain access to GeneChip technology for use in gene expression monitoring and genotyping applications. The companies said they also plan to continue collaborative work focused on optimizing chip-based single-nucleotide polymorphism genotyping applications.

Kari Stefansson, president and CEO of DeCode, said the agreement fits in with DeCode's plans to add alternative gene discovery and gene function tools to its existing technology portfolio.

Filed under

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.